Article info
Image of the moment
A treatable hypertrophic neuropathy
- Correspondence to Dr Nathan P Staff, Department of Neurology, Mayo Clinic, Rochester, MN 55905, USA; staff.nathan{at}mayo.edu
Citation
A treatable hypertrophic neuropathy
Publication history
- Accepted November 2, 2018
- First published November 17, 2018.
Online issue publication
January 17, 2019
Article Versions
- Previous version (17 January 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Ultrasound in the diagnosis of peripheral neuropathy: structure meets function in the neuromuscular clinic
- Clinicopathological characteristics of subtypes of chronic inflammatory demyelinating polyradiculoneuropathy
- Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study
- Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database
- A practical approach to enlargement of nerves, plexuses and roots
- Hypertrophy of multiple cranial nerves and spinal roots in chronic inflammatory demyelinating neuropathy
- CIDP: mimics and chameleons
- Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy
- Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP
- Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype